Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 638Head and Neck Neoplasms 609Carcinoma, Non-Small-Cell Lung 202Thyroid Neoplasms 200Melanoma 145Nasopharyngeal Carcinoma 136Oropharyngeal Neoplasms 129Colorectal Neoplasms 129Mouth Neoplasms 128Neoplasms 113Breast Neoplasms 112Ovarian Neoplasms 105Lung Neoplasms 105Uterine Cervical Neoplasms 101Neoplasm Metastasis 93Carcinoma, Squamous Cell 86Stomach Neoplasms 84Carcinoma, Renal Cell 84Triple Negative Breast Neoplasms 79Pancreatic Neoplasms 72Esophageal Neoplasms 70Laryngeal Neoplasms 67Endometrial Neoplasms 67Urinary Bladder Neoplasms 61Sarcoma 58Prostatic Neoplasms 55Thyroid Cancer, Papillary 54Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 47Carcinoma, Hepatocellular 46

Interventions

vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial medullary thyroid carcinoma × Head & Neck × 1 year × Clear all
NCT00410761 2025-09-24

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

Sanofi

Phase 3 Completed
331 enrolled 15 charts
EndocrineHead & Neck

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡